Patents Assigned to DXTERITY DIAGNOSTICS
  • Patent number: 10829803
    Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In accordance with the invention, the presence of the target(s) of interest can be determined by measuring the presence or amount of ligated oligonucleotide product.
    Type: Grant
    Filed: May 10, 2007
    Date of Patent: November 10, 2020
    Assignee: DXTERITY DIAGNOSTICS INCORPORATED
    Inventor: Robert Terbrueggen
  • Patent number: 10463347
    Abstract: The present invention generally relates to devices and methods for collecting and stabilizing biological samples, and more particularly, for collecting and stabilizing blood or other bodily fluids from a user's fingertip, earlobe, heel or other locations. The present invention also relates to sample collection devices that simplify the process for mixing the biological samples with an additive or additives, provide for efficient storage and safe transport of the samples, and provide for easy access to the samples for subsequent processing.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: November 5, 2019
    Assignee: DXTERITY DIAGNOSTICS INCORPORATED
    Inventors: Robert Terbrueggen, Scott Gordon Beach
  • Patent number: 10066257
    Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: September 4, 2018
    Assignee: DXTERITY DIAGNOSTICS INCORPORATED
    Inventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, Jr., Chang Hee Kim, Majid R. Abedi
  • Patent number: 9976177
    Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In one aspect, the ligation product is of variable length that correlates with a particular target. Following chemical ligation, the probes may be amplified and detected by capillary electrophoresis or microarray analysis.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: May 22, 2018
    Assignee: DXTERITY DIAGNOSTICS INCORPORATED
    Inventor: Robert Terbrueggen
  • Patent number: 9757095
    Abstract: The present invention generally relates to devices and methods for collecting and stabilizing biological samples, and more particularly, for collecting and stabilizing blood or other bodily fluids from a user's fingertip, earlobe, heel or other locations. The present invention also relates to sample collection devices that simplify the process for mixing the biological samples with an additive or additives, provide for efficient storage and safe transport of the samples, and provide for easy access to the samples for subsequent processing.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: September 12, 2017
    Assignee: DXTERITY DIAGNOSTICS INCORPORATED
    Inventors: Robert Terbrueggen, Scott Gordon Beach
  • Patent number: 9745616
    Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: August 29, 2017
    Assignee: DXTERITY DIAGNOSTICS INCORPORATED
    Inventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, Jr., Chang Hee Kim, Majid R. Abedi
  • Publication number: 20140171338
    Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.
    Type: Application
    Filed: May 17, 2012
    Publication date: June 19, 2014
    Applicant: DXTERITY DIAGNOSTICS INCORPORATED
    Inventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, Chang Hee Kim, Majid R. Abedi
  • Publication number: 20080124810
    Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In accordance with the invention, the presence of the target(s) of interest can be determined by measuring the presence or amount of ligated oligonucleotide product.
    Type: Application
    Filed: May 10, 2007
    Publication date: May 29, 2008
    Applicant: DXTERITY DIAGNOSTICS
    Inventor: Robert Terbrueggen